HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone von Day, Kathleen C, Lorenzatti Hiles, Guadalupe, Kozminsky, Molly, Dawsey, Scott J, Paul, Alyssa, Broses, Luke J, Shah, Rajal, Kunja, Lakshmi P, Hall, Christopher, Palanisamy, Nallasivam, Daignault-Newton, Stephanie, El-Sawy, Layla, Wilson, Steven James, Chou, Andrew, Ignatoski, Kathleen Woods, Keller, Evan, Thomas, Dafydd, Nagrath, Sunitha, Morgan, Todd, Day, Mark L

Volltext

HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab von ITHIMAKIN, Suthinee, DAY, Kathleen C, HALL, Christopher L, PALANISAMY, Nallasivam, HEATH, Amber N, TAWAKKOL, Nader, LUTHER, Tahra K, CLOUTHIER, Shawn G, CHADWICK, Whitney A, DAY, Mark L, KLEER, Celina G, THOMAS, Dafydd G, MALIK, Fayaz, HAYES, Daniel F, KORKAYA, Hasan, WICHA, Max S, QIN ZEN, DAWSEY, Scott J, BERSANO-BEGEY, Tom F, QURAISHI, Ahmed A, IGNATOSKI, Kathleen Woods, DAIGNAULT, Stephanie, DAVIS, April

Volltext

The Ectodomain Shedding of E-cadherin by ADAM15 Supports ErbB Receptor Activation von Najy, Abdo J., Day, Kathleen C., Day, Mark L.

Volltext

Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics von Niu, Zeqi, Kozminsky, Molly, Day, Kathleen C., Broses, Luke J., Henderson, Marian L., Patsalis, Christopher, Tagett, Rebecca, Qin, Zhaoping, Blumberg, Sarah, Reichert, Zachery R., Merajver, Sofia D., Udager, Aaron M., Palmbos, Phillip L., Nagrath, Sunitha, Day, Mark L.

Volltext

Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications von Hovelson, Daniel H., Udager, Aaron M., McDaniel, Andrew S., Grivas, Petros, Palmbos, Phillip, Tamura, Shuzo, Lazo de la Vega, Lorena, Palapattu, Ganesh, Veeneman, Brendan, El-Sawy, Layla, Sadis, Seth E., Morgan, Todd M., Montgomery, Jeffrey S., Weizer, Alon Z., Day, Kathleen C., Neamati, Nouri, Liebert, Monica, Keller, Evan T., Day, Mark L., Mehra, Rohit, Tomlins, Scott A.

Volltext

ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer von Lorenzatti Hiles, Guadalupe, Bucheit, Amanda, Rubin, John R, Hayward, Alexandra, Cates, Angelica L, Day, Kathleen C, El-Sawy, Layla, Kunju, L Priya, Daignault, Stephanie, Lee, Cheryl T, Liebert, Monica, Hussain, Maha, Day, Mark L

Volltext

EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells von Grabowska, Magdalena M., Sandhu, Brindar, Day, Mark L.

Volltext

Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway von MCCABE, Michael T, DAVIS, Joanne N, DAY, Mark L

Volltext

Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer von DAVIS, Joanne N, WOJNO, Kirk J, DAIGNAULT, Stephanie, HOFER, Matthias D, KUEFER, Rainer, RUBIN, Mark A, DAY, Mark L

Volltext

Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer von MCCABE, Michael T, LOW, Jonathan A, DAIGNAULT, Stephanie, IMPERIALE, Michael J, WOJNO, Kirk J, DAY, Mark L

Volltext

Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer von Grivas, Petros D, Day, Kathleen C, Karatsinides, Andreas, Paul, Alyssa, Shakir, Nazia, Owainati, Iya, Liebert, Monica, Kunju, Lakshmi P, Thomas, Dafydd, Hussain, Maha, Day, Mark L

Volltext

The Role of Calpain in the Proteolytic Cleavage of E-cadherin in Prostate and Mammary Epithelial Cells von Rios-Doria, Jonathan, Day, Kathleen C., Kuefer, Rainer, Rashid, Michael G., Chinnaiyan, Arul M., Rubin, Mark A., Day, Mark L.

Volltext

Repression of androgen receptor transcription through the E2F1/DNMT1 axis von Valdez, Conrad David, Davis, Joanne N, Odeh, Hana M, Layfield, Tristan L, Cousineau, Craig S, Berton, Thomas R, Johnson, David G, Wojno, Kirk J, Day, Mark L

Volltext

ADAM15 Disintegrin Is Associated with Aggressive Prostate and Breast Cancer Disease von Kuefer, Rainer, Day, Kathleen C., Kleer, Celina G., Sabel, Michael S., Hofert, Matthias D., Varambally, Sooryanarayana, Zorn, Christoph S., Chinnaiyan, Arul M., Rubin, Mark A., Day, Mark L.

Volltext

CXCL12 Activates a Robust Transcriptional Response in Human Prostate Epithelial Cells von Begley, Lesa A., MacDonald, James W., Day, Mark L., Macoska, Jill A.

Volltext

Soluble E-cadherin: more than a symptom of disease von Grabowska, Magdalena M, Day, Mark L

Volltext

E-cadherin expression in prostate cancer: A broad survey using high-density tissue microarray technology von Rubin, Mark A., Mucci, Neil R., Figurski, Jay, Fecko, Alice, Pienta, Kenneth J., Day, Mark L.

Volltext

A surgical orthotopic approach for studying the invasive progression of human bladder cancer von Lorenzatti Hiles, Guadalupe, Cates, Angelica L., El-Sawy, Layla, Day, Kathleen C., Broses, Luke J., Han, Amy L., Briggs, Hannah L., Emamdjomeh, Amir, Chou, Andrew, Abel, Ethan V., Liebert, Monica, Palmbos, Phillip L., Udager, Aaron M., Keller, Evan T., Day, Mark L.

Volltext

5-Aza-2′-Deoxycytidine Delays Androgen-Independent Disease and Improves Survival in the Transgenic Adenocarcinoma of the Mouse Prostate Mouse Model of Prostate Cancer von Zorn, Christoph S, Wojno, Kirk J, McCabe, Michael T, Kuefer, Rainer, Gschwend, Juergen E, Day, Mark L

Volltext

ATDC mediates a TP63-regulated basal cancer invasive program von Palmbos, Phillip L., Wang, Yin, Bankhead III, Armand, Kelleher, Alan J., Wang, Lidong, Yang, Huibin, Ahmet, McKenzie L., Gumkowski, Erica R., Welling, Samuel D., Magnuson, Brian, Leflein, Jacob, Lorenzatti Hiles, Guadalupe, Abel, Ethan V., Dziubinski, Michele L., Urs, Sumithra, Day, Mark L., Ljungman, Mats E., Simeone, Diane M.

Volltext